Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States

References

• Centers for Disease Control and Prevention (CDC). Most recent National asthma data. 2018 Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm. Accessed 330, 2020.
   Google Scholar
• Zahran HS, Bailey CM, Damon SA, Garbe PL, Breysse PN. Vital signs: asthma in children – united States, 2001–2016. Morbidity Mortality Weekly Rep. 2018;67(5):149–155. doi:10.15585/mmwr.mm6705e1
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Asthma-related missed school days among children aged 5–17 years; 2013 Available from: https://www.cdc.gov/asthma/asthma_stats/missing_days.htm. Accessed 330, 2020..
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Asthma facts: CDC’s National asthma control program grantees, 2013 Available from: https://www.cdc.gov/asthma/pdfs/asthma_facts_program_grantees.pdf. Accessed 330, 2020.
   Google Scholar
• Chastek B, Korrer S, Nagar SP, et al. Economic burden of illness among patients with severe asthma in a managed care setting. J Manag Care Spec Pharm. 2016;22(7):848–861. doi:10.18553/jmcp.2016.22.7.84827348285
   PubMedGoogle Scholar
• Lee YJ, Kwon SH, Hong SH, et al. Health care utilization and direct costs in mild, moderate, and severe adult asthma: a descriptive study using the 2014 South Korean Health Insurance database. Clin Ther. 2017;39(3):527–536. doi:10.1016/j.clinthera.2017.01.02528196623
   PubMed Web of Science ®Google Scholar
• Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111(6):1212–1218. doi:10.1067/mai.2003.144912789219
   PubMed Web of Science ®Google Scholar
• Miller GF, Coffield E, Leroy Z, Wallin R. Prevalence and costs of five chronic conditions in children. J Sch Nurs. 2016;32(5):357–364. doi:10.1177/105984051664119027044668
   PubMed Web of Science ®Google Scholar
• Sullivan P, Ghushchyan VG, Navaratnam P, et al. School absence and productivity outcomes associated with childhood asthma in the USA. J Asthma. 2018;55(2):161–168. doi:10.1080/02770903.2017.131327328453370
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Slejko JF, et al. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2011;127(2):363–369. doi:10.1016/j.jaci.2010.10.04221281868
   PubMed Web of Science ®Google Scholar
• Wu CH, Erickson SR. The association between asthma and absenteeism among working adults in the United States: results from the 2008 Medical Expenditure Panel Survey. J Asthma. 2012;49(7):757–764. doi:10.3109/02770903.2012.70929222891960
   PubMed Web of Science ®Google Scholar
• Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol. 2011;127(1):145–152. doi:10.1016/j.jaci.2010.10.02021211649
   PubMed Web of Science ®Google Scholar
• Rappaport H, Bonthapally V. The direct expenditures and indirect costs associated with treating asthma in the United States. J Aller Ther. 2012;3(2):118. doi:10.4172/2155-6121.1000118
   Google Scholar
• Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma. 2009;46(1):73–80. doi:10.1080/0277090080250310719191142
   PubMed Web of Science ®Google Scholar
• Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC29323930
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Panel Survey (MEPS). Available from: https://meps.ahrq.gov/mepsweb/. Accessed 3 24, 2020.
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2010 Available from: https://ginasthma.org/archived-reports/. Accessed 324, 2020.
   Google Scholar
• Kang HR, Song HJ, Nam JH, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 2018;8(3):e020825. doi:10.1136/bmjopen-2017-020825
   PubMed Web of Science ®Google Scholar
• Gupte-Singh K, Singh RR, Lawson KA. Economic burden of attention-deficit/hyperactivity disorder among pediatric patients in the United States. Value Health. 2017;20(4):602–609. doi:10.1016/j.jval.2017.01.00728408002
   PubMed Web of Science ®Google Scholar
• Flórez-Tanus A, Parra D, Zakzuk J, et al. Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis. World Allergy Organ J. 2018;11(1):26. doi:10.1186/s40413-018-0205-430459927
   PubMed Web of Science ®Google Scholar
• Pagano E, Petrelli A, Picariello R, et al. Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry. BMC Health Serv Res. 2015;15(1):582. doi:10.1186/s12913-015-1241-126714744
   PubMed Web of Science ®Google Scholar
• Mihaylova B, Briggs A, O’Hagan A, Thompson SG. Review of statistical methods for analyzing healthcare resources and costs. Health Econ. 2011;20(8):897–916. doi:10.1002/hec.165320799344
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Ou HT, Wang F, Erickson SR. A new comorbidity index: the health-related quality of life comorbidity index. J Clin Epidemiol. 2011;64(3):309–319. doi:10.1016/j.jclinepi.2010.01.02521147517
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.8316224307
   PubMed Web of Science ®Google Scholar
• Marsh T Here’s why asthma inhalers are so expensive. 2018 Available from: https://www.goodrx.com/blog/heres-why-asthma-inhalers-are-so-expensive/. Accessed 46, 2020..
   Google Scholar
• Nagase H, Adachi M, Matsunaga K, et al. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergol Int. 2020;69(1):53–60. doi:10.1016/j.alit.2019.06.00331311707
   PubMed Web of Science ®Google Scholar
• Haddix AC, Teutsch SM, Corso PS. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. 2nd ed. New York: Oxford University Press; 2003.
   Google Scholar
• Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
   Google Scholar
• Schmitt J, Wüstenberg E, Küster D, et al. The moderating role of allergy immunotherapy in asthma progression: results of a population-based cohort study. Allergy. 2020;75(3):596–602. doi:10.1111/all.1402031408535
   PubMed Web of Science ®Google Scholar